Literature DB >> 21300050

The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.

D Matthew Walentiny1, Thomas F Gamage, Jonathan A Warner, Thanh K Nguyen, Darren B Grainger, Jenny L Wiley, Robert E Vann.   

Abstract

The endogenous cannabinoid system has been noted for its therapeutic potential, as well as the psychoactivity of cannabinoids such as Δ9-tetrahydrocannabinol (THC). However, less is known about the psychoactivity of anandamide (AEA), an endocannabinoid ligand. Thus, the goals of this study were to establish AEA as a discriminative stimulus in transgenic mice lacking fatty acid amide hydrolase (i.e., FAAH -/- mice unable to rapidly metabolize AEA), evaluate whether THC or oleamide, a fatty acid amide, produced AEA-like responding, and assess for CB(1) mediation of AEA's discriminative stimulus. Mice readily discriminated between 6mg/kg AEA and vehicle in a two-lever drug discrimination task. AEA dose-dependently generalized to itself. THC elicited full AEA-like responding, whereas oleamide failed to substitute. The CB(1) antagonist rimonabant attenuated AEA- and THC-induced AEA-appropriate responding, demonstrating CB(1) mediation of AEA's discriminative stimulus. These findings suggest that, in the absence of FAAH, AEA produces intoxication comparable to THC, and consequently to marijuana.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300050      PMCID: PMC3071597          DOI: 10.1016/j.ejphar.2011.01.056

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  51 in total

1.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.

Authors:  D Matthew Walentiny; Robert E Vann; Jonathan A Warner; Lindsey S King; Herbert H Seltzman; Hernán A Navarro; Charles E Twine; Brian F Thomas; Anne F Gilliam; Brian P Gilmour; F Ivy Carroll; Jenny L Wiley
Journal:  Psychopharmacology (Berl)       Date:  2010-03-31       Impact factor: 4.530

Review 3.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

4.  (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.

Authors:  T U Järbe; R J Lamb; S Lin; A Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2001-08       Impact factor: 4.530

Review 5.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

Review 6.  Cannabinoid receptors and their ligands.

Authors:  R G Pertwee; R A Ross
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

7.  Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.

Authors:  James D Leggett; S Aspley; S R G Beckett; A M D'Antona; D A Kendall; D A Kendall
Journal:  Br J Pharmacol       Date:  2004-01-05       Impact factor: 8.739

8.  Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.

Authors:  Aron H Lichtman; Christopher C Shelton; Tushar Advani; Benjamin F Cravatt
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

9.  A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.

Authors:  Jenny L Wiley; Kari L LaVecchia; Natalie E Karp; Sanjitha Kulasegram; Anu Mahadevan; Raj K Razdan; Billy R Martin
Journal:  Exp Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.157

10.  Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.

Authors:  Aron H Lichtman; E Gregory Hawkins; Graeme Griffin; Benjamin F Cravatt
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

View more
  8 in total

1.  Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Authors:  Jenny L Wiley; D Matthew Walentiny; M Jerry Wright; Patrick M Beardsley; James J Burston; Justin L Poklis; Aron H Lichtman; Robert E Vann
Journal:  Eur J Pharmacol       Date:  2014-05-22       Impact factor: 4.432

2.  Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

Authors:  Jenny L Wiley; D Matthew Walentiny; Robert E Vann; Cassandra Y Baskfield
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.

Authors:  R E Vann; D M Walentiny; J J Burston; K M Tobey; T F Gamage; J L Wiley
Journal:  Neuropharmacology       Date:  2011-10-31       Impact factor: 5.250

4.  Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.

Authors:  Michael Z Leonard; Shakiru O Alapafuja; Lipin Ji; Vidyanand G Shukla; Yingpeng Liu; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman; Brian D Kangas
Journal:  J Pharmacol Exp Ther       Date:  2017-09-25       Impact factor: 4.030

5.  Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.

Authors:  D Matthew Walentiny; Robert E Vann; Jenny L Wiley
Journal:  Neuropharmacology       Date:  2015-02-16       Impact factor: 5.250

Review 6.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

7.  Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.

Authors:  Robert A Owens; Mohammed A Mustafa; Bogna M Ignatowska-Jankowska; M Imad Damaj; Patrick M Beardsley; Jenny L Wiley; Micah J Niphakis; Benjamin F Cravatt; Aron H Lichtman
Journal:  Neuropharmacology       Date:  2017-06-30       Impact factor: 5.250

8.  Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice.

Authors:  Jenny L Wiley; Timothy W Lefever; Nikita S Pulley; Julie A Marusich; Benjamin F Cravatt; Aron H Lichtman
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.